S&P 500 Futures
(0.37%) 5 110.25 points
Dow Jones Futures
(0.79%) 38 685 points
Nasdaq Futures
(0.64%) 17 763 points
Oil
(-0.10%) $78.87
Gas
(-0.34%) $2.03
Gold
(0.02%) $2 310.00
Silver
(-0.09%) $26.81
Platinum
(1.71%) $979.10
USD/EUR
(-0.15%) $0.931
USD/NOK
(-0.68%) $10.92
USD/GBP
(-0.20%) $0.796
USD/RUB
(0.43%) $91.52

Echtzeitaktualisierungen für Laboratory Corporation of [LH]

Börse: NYSE Sektor: Healthcare Industrie: Diagnostics & Research
Zuletzt aktualisiert2 Mai 2024 @ 22:00

-0.53% $ 200.25

Live Chart Being Loaded With Signals

Commentary (2 Mai 2024 @ 22:00):

Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions...

Stats
Tagesvolumen 500 028
Durchschnittsvolumen 799 177
Marktkapitalisierung 16.84B
EPS $0 ( 2024-04-25 )
Nächstes Ertragsdatum ( $3.80 ) 2024-07-25
Last Dividend $0.720 ( 2023-11-07 )
Next Dividend $0 ( N/A )
P/E 42.88
ATR14 $0.0910 (0.05%)
Insider Trading
Date Person Action Amount type
2024-04-30 Anderson Kerrii B Sell 250 Common Stock
2024-05-02 Anderson Kerrii B Sell 250 Common Stock
2024-04-30 Eisenberg Glenn A Buy 10 229 Common Stock
2024-04-30 Eisenberg Glenn A Sell 4 496 Common Stock
2024-04-30 Eisenberg Glenn A Sell 10 229 Performance Share Unit
INSIDER POWER
-11.09
Last 100 transactions
Buy: 259 185 | Sell: 319 041

Volumen Korrelation

Lang: -0.10 (neutral)
Kurz: 0.96 (very strong)
Signal:(72.043) Expect same movement, but be aware

Laboratory Corporation of Korrelation

10 Am meisten positiv korreliert
10 Am meisten negativ korreliert

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Laboratory Corporation of Korrelation - Währung/Rohstoff

The country flag 0.63
( weak )
The country flag 0.59
( weak )
The country flag 0.00
( neutral )
The country flag 0.66
( moderate )
The country flag 0.75
( moderate )
The country flag 0.72
( moderate )

Laboratory Corporation of Finanzdaten

Annual 2023
Umsatz: $12.16B
Bruttogewinn: $3.15B (25.86 %)
EPS: $4.80
FY 2023
Umsatz: $12.16B
Bruttogewinn: $3.15B (25.86 %)
EPS: $4.80
FY 2022
Umsatz: $14.88B
Bruttogewinn: $4.39B (29.48 %)
EPS: $14.04
FY 2021
Umsatz: $16.12B
Bruttogewinn: $5.62B (34.89 %)
EPS: $24.60

Financial Reports:

No articles found.

Laboratory Corporation of Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0.720
(N/A)
$0.720
(N/A)
$0.720
(N/A)
$0.720
(N/A)
$0.720
(N/A)
$0.720
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Laboratory Corporation of Dividend Information - Dividend Junior

Dividend Sustainability Score: 8.88 - good (88.78%) | Divividend Growth Potential Score: 5.15 - Stable (3.03%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend $0.150 1990-12-31
Last Dividend $0.720 2023-11-07
Next Dividend $0 N/A
Payout Date 2023-12-12
Next Payout Date N/A
# dividends 21 --
Total Paid Out $7.64 --
Avg. Dividend % Per Year 0.54% --
Score 2.73 --
Div. Sustainability Score 8.88
Div.Growth Potential Score 5.15
Div. Directional Score 7.01 --
Next Divdend (Est)
(2025-06-04)
$0.751 Estimate 31.20 %
Dividend Stability
0.62 Above Average
Dividend Score
2.73
Pay Frequency
Sporadic
Yearly Payout
Year Amount Yield
1990 $0.150 0.61%
1991 $0.500 2.19%
1992 $0.950 1.59%
1993 $0.800 2.11%
1994 $0.200 0.65%
1995 $0 0.00%
1996 $0 0.00%
1997 $0 0.00%
1998 $0 0.00%
1999 $0 0.00%
2000 $0 0.00%
2001 $0 0.00%
2002 $0 0.00%
2003 $0 0.00%
2004 $0 0.00%
2005 $0 0.00%
2006 $0 0.00%
2007 $0 0.00%
2008 $0 0.00%
2009 $0 0.00%
2010 $0 0.00%
2011 $0 0.00%
2012 $0 0.00%
2013 $0 0.00%
2014 $0 0.00%
2015 $0 0.00%
2016 $0 0.00%
2017 $0 0.00%
2018 $0 0.00%
2019 $0 0.00%
2020 $0 0.00%
2021 $0 0.00%
2022 $2.16 0.84%
2023 $2.88 1.41%
2024 $0 0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for NYSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
LOMA Dividend Knight 2023-06-30 Quarterly 2 5.23% 8.53
PHK Dividend Royal 2023-11-10 Monthly 22 6.88% 8.50
ZTR Dividend King 2024-02-09 Monthly 37 8.35% 8.50
PCF Dividend King 2023-12-18 Monthly 38 7.05% 8.50
PVL Dividend King 2023-11-15 Monthly 14 9.37% 8.50
KIO Dividend Royal 2023-12-14 Monthly 12 7.05% 8.50
NCV Dividend Royal 2024-02-09 Monthly 22 7.68% 8.50
SBR Dividend Royal 2023-11-14 Monthly 38 7.74% 8.50
SCM Dividend King 2023-12-15 Monthly 13 7.08% 8.50
MTR Dividend Diamond 2023-10-30 Monthly 39 10.10% 8.50

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.03521.5009.3010.00[0 - 0.5]
returnOnAssetsTTM0.02621.2009.1310.00[0 - 0.3]
returnOnEquityTTM0.05331.500-0.518-0.778[0.1 - 1]
payoutRatioTTM0.581-1.0004.19-4.19[0 - 1]
currentRatioTTM0.8770.800-0.615-0.492[1 - 3]
quickRatioTTM0.5840.800-1.268-1.015[0.8 - 2.5]
cashRatioTTM0.02521.500-0.971-1.457[0.2 - 2]
debtRatioTTM0.319-1.5004.69-7.03[0 - 0.6]
interestCoverageTTM5.501.0009.079.07[3 - 30]
operatingCashFlowPerShareTTM13.992.005.3410.00[0 - 30]
freeCashFlowPerShareTTM7.952.006.0310.00[0 - 20]
debtEquityRatioTTM0.662-1.5007.35-10.00[0 - 2.5]
grossProfitMarginTTM0.2681.0008.878.87[0.2 - 0.8]
operatingProfitMarginTTM0.08751.000-0.249-0.249[0.1 - 0.6]
cashFlowToDebtRatioTTM0.2231.0009.879.87[0.2 - 2]
assetTurnoverTTM0.7440.8008.376.70[0.5 - 2]
Total Score8.88

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM38.881.0006.170[1 - 100]
returnOnEquityTTM0.05332.50-0.333-0.778[0.1 - 1.5]
freeCashFlowPerShareTTM7.952.007.3510.00[0 - 30]
dividendYielPercentageTTM1.3881.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM13.992.005.3410.00[0 - 30]
payoutRatioTTM0.5811.5004.19-4.19[0 - 1]
pegRatioTTM2.261.50010.000[0.5 - 2]
operatingCashFlowSalesRatioTTM0.09571.000-0.1080[0.1 - 0.5]
Total Score5.15

Laboratory Corporation of

Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, and parentage and donor testing; and occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests. It provides online and mobile applications to enable patients to check test results; and online applications for managed care organizations and accountable care organizations. It offers end-to-end drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development and commercial market access. It serves managed care organizations, pharmaceutical, biotechnology, medical device and diagnostics companies, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, and independent clinical laboratories. Laboratory Corporation of America Holdings has a collaboration agreement with Tigerlily Foundation to increase clinical trial diversity for women of color. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina.

Über Live-Signale

Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.

Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.